Greg Louden

Greg Louden is an experienced sales professional in the pharmaceutical industry, currently serving as Regional Sales Director at Merz Therapeutics since July 2024. Previously, Louden worked as Regional Business Director at BioXcel Therapeutics, focusing on acute care and team development for a novel agent launch. At Alexion Pharmaceuticals, Louden held the position of Institutional Regional Sales Director, overseeing the implementation of a IV reversal therapy for critical patients. Louden's career includes roles at Portola Pharmaceuticals, where the launch of Andexxa was nationally successful, and Allergan, where management of anti-infective agents and treatments was emphasized. Earlier experience includes positions at Gilead Sciences and sanofi-aventis, where Louden developed skills in recruitment and sales of specialty medications, achieving notable recognition. Louden holds a BA in Political Science/Economics from Colorado State University.